Dr. Oz Is Confirmed to Lead Medicare and Medicaid. Here's What He's Said About the Programs So Far.

Source The Motley Fool

Congress recently confirmed President Donald Trump's pick, Dr. Mehmet Oz, to lead the Centers for Medicare and Medicaid Services (CMS). Medicare and Medicaid provide healthcare insurance to an estimated 136 million Americans, with Medicare serving citizens 65 and older and Medicaid covering lower-income populations. The appointment comes as healthcare remains expensive and out of reach for many Americans, and as Republicans try to figure out ways to improve the country's fiscal situation.

Oz previously served as the vice chair and professor of surgery at Columbia University, and also directed the Cardiovascular Institute and Complementary Medicine Program at the NewYork-Presbyterian Hospital. He's also published five best-selling books, and hosted his own television show and radio talk show.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Here is what he's said so far about the Medicare and Medicaid programs.

What Dr. Oz said (or didn't say) about Medicaid cuts

Both Medicare and Medicaid have been big topics of conversation this year. The programs are enormously costly at a time when the U.S. government just ran a $1.8 billion deficit in fiscal year 2024, meaning it's spending more than the revenue it collects annually. Total U.S. debt now exceeds $36 trillion.

In late February, the U.S. House of Representatives passed a budget resolution that directed the agency overseeing Medicaid to find $880 billion in savings over the next decade. Many surmise this wouldn't be possible without cuts to Medicaid. Although Trump supported the resolution, he also publicly said that programs like Medicare and Medicaid would not be cut. Senate Republicans, however, have shown some pushback on potential actions that could lead to cuts to Medicaid.

So far, Oz has been tight-lipped on what he thinks about potential cuts to Medicaid, dodging questions during his hearings about the proposals. "I cherish Medicaid," he said, but it must be "viable at every level."

He did provide some comments on past changes to the program, such as its expansion under Obamacare. In one of his hearings, Oz said he supports work requirements for receiving Medicaid coverage, although he doesn't necessarily think paperwork should be a barrier for enrollment. He also said that the program was expanded without providing more resources to doctors, and that doctors don't like the program due to its lower payments.

These problems, among others, have left the program at a critical juncture. "We have to make some important decisions to improve the quality of care," said Oz, according to CBS.

Two people at a dining-room table looking at a laptop and documents.

Image source: Getty Images.

Thoughts on Medicare Advantage and Biden's changes

Medicare Advantage ("Part C") has long been controversial. The program allows private insurance companies to work with the government to provide all other parts of Medicare (A, B, and D) to citizens. Frequent complaints about Medicare Advantage allege that private insurance companies take advantage of the program, by cherry-picking healthier or younger patients and diagnosing patients with more issues in order to receive higher payouts from the government.

"There's a new sheriff in town," Oz said, according to The Wall Street Journal. He was critical of practices by insurance companies that overdiagnose: "I pledge if confirmed I will go after it." However, some senators felt uncomfortable with Oz's past on Medicare Advantage, because he has filmed videos on YouTube promoting the program. In 2020, he also penned an op-ed suggesting that Medicare Advantage could be used to provide healthcare to everyone, while putting the nation's healthcare system on a sounder fiscal footing.

Oz does seem supportive of work that CMS began under former President Joe Biden thanks to the Inflation Reduction Act, which let the agency begin negotiating prices on drugs frequently covered by Medicare and Medicaid.

In 2023, CMS negotiated lower prices on 10 drugs frequently used under Medicare and Medicaid that were expensive for consumers. Earlier this year, negotiations on another 15 drugs were announced. These negotiations are expected to save Americans billions of dollars in out-of-pocket expenses once they go into effect, starting next year.

Of the price negotiation program, Oz said: "It's the law. I'm going to defend it and use it."

The $22,924 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income. For example: one easy trick could pay you as much as $22,924 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Simply click here to discover how to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Solana (SOL) Price Underwhelms, Experts Believe Cardano (ADA) and Mutuum Finance (MUTM) Are Set To SkyrocketThe crypto market suffers from jitters which have forced Solana (SOL) to decline 15% resulting in its current price of $131. Whales sold $26 million worth of SOL tokens while founder Anatoly Yakovenko failed to improve the situation through his comparisons of U.S. bonds to the MicroStrategy financial problems.
Author  Cryptopolitan
12 hours ago
The crypto market suffers from jitters which have forced Solana (SOL) to decline 15% resulting in its current price of $131. Whales sold $26 million worth of SOL tokens while founder Anatoly Yakovenko failed to improve the situation through his comparisons of U.S. bonds to the MicroStrategy financial problems.
placeholder
Trump joins Japan trade talks in surprise move, claims ‘big progress’ on tariff disputePresident Donald Trump entered the early stage of tariff negotiations with Japan on Wednesday, escalating what could have been a preparatory discussion into a diplomatic negotiation procedure.
Author  Cryptopolitan
13 hours ago
President Donald Trump entered the early stage of tariff negotiations with Japan on Wednesday, escalating what could have been a preparatory discussion into a diplomatic negotiation procedure.
placeholder
EUR/GBP trades in the red below 0.8600 mark ahead of ECB rate decisionThe EUR/GBP cross struggles to capitalize on the previous day's goodish rebound from the 0.8525-0.8520 area or a fresh weekly low and attracts some intraday sellers on Thursday.
Author  FXStreet
13 hours ago
The EUR/GBP cross struggles to capitalize on the previous day's goodish rebound from the 0.8525-0.8520 area or a fresh weekly low and attracts some intraday sellers on Thursday.
placeholder
Whales withdraw 14,929 BTC from Babylon LabsBabylon Labs saw an outflow of non-custodial staking, with 14,929 BTC sent to external addresses.
Author  Cryptopolitan
13 hours ago
Babylon Labs saw an outflow of non-custodial staking, with 14,929 BTC sent to external addresses.
placeholder
U.S.-Japan Talks Avoid Yen Exchange Rate, BOJ Likely to Cut Growth Forecasts Amid Uncertain Rate Hike ProspectsThe United States and Japan have begun negotiations on tariff-related issues, with statements from President Donald Trump and the Japanese delegation causing fluctuations in the yen exchange rate.
Author  TradingKey
13 hours ago
The United States and Japan have begun negotiations on tariff-related issues, with statements from President Donald Trump and the Japanese delegation causing fluctuations in the yen exchange rate.
goTop
quote